PR Newswire Health·· 21 小时前AI 评分58
药明康德2026年前三季度业绩强劲并再度上调全年指引
WuXi AppTec Delivers Strong Q1-Q3 2026 Results and Further Raises Full-Year Guidance, Driven by Greater Success of Multiple Customers' Products and CRDMO Model
AI 导读
药明康德公布2026年前三季度业绩，总收入455.4亿元，同比增长38.6%，持续经营业务收入同比增长46.3%，经调整non-IFRS净利润183.8亿元，同比增长74.4%。
来源：PR Newswire Health · prnewswire.com